BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 30805775)

  • 1. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
    Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-Targeted Microbubble Destruction Enhances Inhibitory Effect of Apatinib on Angiogenesis in Triple Negative Breast Carcinoma Xenografts.
    Hong D; Yang J; Guo J; Zhang Y; Chen Z
    Anal Cell Pathol (Amst); 2021; 2021():8837950. PubMed ID: 33959473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound Microbubble Delivery Targeting Intraplaque Neovascularization Inhibits Atherosclerotic Plaque in an APOE-deficient Mouse Model.
    Yuan H; Hu H; Sun J; Shi M; Yu H; Li C; Sun YU; Yang Z; Hoffman RM
    In Vivo; 2018; 32(5):1025-1032. PubMed ID: 30150423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles.
    Spivak I; Rix A; Schmitz G; Fokong S; Iranzo O; Lederle W; Kiessling F
    Mol Imaging Biol; 2016 Apr; 18(2):180-90. PubMed ID: 26391990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Walker-256 Tumor Growth by Combining Microbubble-Enhanced Ultrasound and Endostar.
    Yu Y; Qiao W; Feng S; Yi C; Liu Z
    J Ultrasound Med; 2022 Oct; 41(10):2591-2600. PubMed ID: 35106800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment.
    Du Y; Zhang Q; Jing L; Liang X; Chi C; Li Y; Yang X; Dai Z; Tian J
    Int J Nanomedicine; 2015; 10():3791-802. PubMed ID: 26060399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model.
    Xu Z; Zhao X; Shu H; Luo W; Dong Y; Xu L; Zhu H; Zhao Q; Lv Y
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):238. PubMed ID: 36042171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].
    Yuan J; Wu CW; Liu ZJ; Wei XY; Li K
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):580-5. PubMed ID: 21122408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer.
    Ji Y; Han Z; Shao L; Zhao Y
    Cancer Med; 2016 Sep; 5(9):2534-43. PubMed ID: 27465833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model.
    Kim E; Tunset HM; Cebulla J; Vettukattil R; Helgesen H; Feuerherm AJ; Engebråten O; Mælandsmo GM; Johansen B; Moestue SA
    BMC Cancer; 2016 Mar; 16():191. PubMed ID: 26951085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles.
    Zhou Y; Gu H; Xu Y; Li F; Kuang S; Wang Z; Zhou X; Ma H; Li P; Zheng Y; Ran H; Jian J; Zhao Y; Song W; Wang Q; Wang D
    Theranostics; 2015; 5(4):399-417. PubMed ID: 25699099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
    Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
    Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
    Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
    PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model.
    Jun HY; Park SH; Kim HS; Yoon KH
    Acad Radiol; 2010 Jan; 17(1):54-60. PubMed ID: 19815430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice.
    You Q; Kong LJ; Li FD; Wang HY; Liu DG; Pei FH; Song JT; Xu J; Chen J
    Mol Med Rep; 2015 Oct; 12(4):5594-600. PubMed ID: 26239504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
    Deng G; Zhao DL; Li GC; Yu H; Teng GJ
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.
    Ling Y; Yang Y; Lu N; You QD; Wang S; Gao Y; Chen Y; Guo QL
    Biochem Biophys Res Commun; 2007 Sep; 361(1):79-84. PubMed ID: 17644065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-targeted photodynamic and gene dual therapy for effectively inhibiting triple negative breast cancer by cationic porphyrin lipid microbubbles loaded with HIF1α-siRNA.
    Sun S; Xu Y; Fu P; Chen M; Sun S; Zhao R; Wang J; Liang X; Wang S
    Nanoscale; 2018 Nov; 10(42):19945-19956. PubMed ID: 30346453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
    Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
    Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
    Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
    PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.